$BCRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.

Page:   < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 28 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM3.7826,455100,000170,756144.3 K to 170.8 K (+18.33 %)
Jul 02 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM4.733,12514,78115,500
Jul 02 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS13.003,12540,625144,301147.4 K to 144.3 K (-2.12 %)
Jul 02 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM4.733,12514,781147,426144.3 K to 147.4 K (+2.17 %)
Jun 24 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM4.733,12514,78118,625
Jun 24 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS12.493,12539,031144,301147.4 K to 144.3 K (-2.12 %)
Jun 24 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM4.733,12514,781147,426144.3 K to 147.4 K (+2.17 %)
Jun 19 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM4.733,12514,78121,750
Jun 19 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS12.003,12537,500144,301147.4 K to 144.3 K (-2.12 %)
Jun 19 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM4.733,12514,781147,426144.3 K to 147.4 K (+2.17 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOOption ExerciseM4.733,42716,21046,573
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOOption ExerciseM6.684,05127,06159,949
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOOption ExerciseM4.1513,75057,06341,250
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOPayment of ExerciseF9.861,64416,210148,173149.8 K to 148.2 K (-1.10 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOBuyM4.733,42716,210149,817146.4 K to 149.8 K (+2.34 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOPayment of ExerciseF9.862,74527,066146,390149.1 K to 146.4 K (-1.84 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOBuyM6.684,05127,061149,135145.1 K to 149.1 K (+2.79 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOPayment of ExerciseF9.865,78857,070145,084150.9 K to 145.1 K (-3.84 %)
Jun 05 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOBuyM4.1513,75057,063150,872137.1 K to 150.9 K (+10.03 %)
May 28 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseA5.4525,000136,25025,000
May 28 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseA5.4517,00092,65017,000
May 28 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOOption ExerciseA5.4517,00092,65017,000
May 28 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseA5.4517,00092,65017,000
May 28 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseA5.4517,00092,65017,000
May 27 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM3.7817,68566,849147,090
May 27 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM3.7817,68566,849144,301126.6 K to 144.3 K (+13.97 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseM4.159,62539,944158,375
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseM6.6826,991180,300116,809
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseM3.263,80112,39156,949
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF7.705,18839,948640,445645.6 K to 640.4 K (-0.80 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOBuyM4.159,62539,944645,633636 K to 645.6 K (+1.51 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF7.7023,416180,303636,008659.4 K to 636 K (-3.55 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOBuyM6.6826,991180,300659,424632.4 K to 659.4 K (+4.27 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF7.701,61012,397632,433634 K to 632.4 K (-0.25 %)
May 12 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOBuyM3.263,80112,391634,043630.2 K to 634 K (+0.60 %)
May 06 2014BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...SANDERS CHARLES ADirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...Jensen PederDirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...Erck Stanley CDirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...Cohen Fred EDirectorOption ExerciseA8.4715,000127,05015,000
May 06 2014BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorOption ExerciseA8.4715,000127,05015,000
Apr 01 2014BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorOption ExerciseM1.714,0006,84011,000
Apr 01 2014BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorBuyM1.714,0006,84010,0006 K to 10 K (+66.67 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseM3.8022,91787,0850
Mar 07 2014BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorSellS12.6912,665160,71910,25222.9 K to 10.3 K (-55.26 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorBuyM3.8022,91787,08522,9170 to 22.9 K
Mar 17 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM4.733,12514,78124,875
Mar 17 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS11.243,12535,125126,616129.7 K to 126.6 K (-2.41 %)
Mar 17 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM4.733,12514,781129,741126.6 K to 129.7 K (+2.47 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM8.8323,679209,0860
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM4.302,92912,5950
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM8.832,20819,4970
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...SellS12.5740,642510,870208,195248.8 K to 208.2 K (-16.33 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM8.8323,679209,086248,837225.2 K to 248.8 K (+10.52 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM4.302,92912,595225,158222.2 K to 225.2 K (+1.32 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM8.832,20819,497222,229220 K to 222.2 K (+1.00 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Payment of ExerciseF11.691,61818,914220,021221.6 K to 220 K (-0.73 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseM1.4210,00014,20090,000
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseM4.152,51810,45027,482
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseM6.686,15641,12235,844
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseM4.7312,50059,12537,500
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...SellS12.6340,734514,47071,622112.4 K to 71.6 K (-36.25 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...BuyM1.4210,00014,200112,356102.4 K to 112.4 K (+9.77 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...BuyM4.152,51810,450102,35699.8 K to 102.4 K (+2.52 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...BuyM6.686,15641,12299,83893.7 K to 99.8 K (+6.57 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...BuyM4.7312,50059,12593,68281.2 K to 93.7 K (+15.40 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Payment of ExerciseF11.691,09012,74281,18282.3 K to 81.2 K (-1.32 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM4.733,00014,19028,000
Mar 07 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS12.693,00038,070126,616129.6 K to 126.6 K (-2.31 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM4.733,00014,190129,616126.6 K to 129.6 K (+2.37 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF11.694615,389126,616127.1 K to 126.6 K (-0.36 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF11.695,11859,829630,242635.4 K to 630.2 K (-0.81 %)
Mar 07 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSenior VP - CMOPayment of ExerciseF11.691,73920,329137,122138.9 K to 137.1 K (-1.25 %)
Feb 25 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseM4.3023,17999,6700
Feb 25 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Payment of ExerciseF12.208,17099,674221,639229.8 K to 221.6 K (-3.56 %)
Feb 25 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...BuyM4.3023,17999,670229,809206.6 K to 229.8 K (+11.22 %)
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseA10.8084,000907,20084,000
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOGrantA0.00128,0000632,360504.4 K to 632.4 K (+25.38 %)
Feb 04 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseA10.8035,000378,00035,000
Feb 04 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...GrantA0.0054,0000126,21872.2 K to 126.2 K (+74.77 %)
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOOption ExerciseA10.8035,000378,00035,000
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOGrantA0.0054,0000136,53982.5 K to 136.5 K (+65.42 %)
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseA10.8018,000194,40018,000
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...GrantA0.0027,000081,48754.5 K to 81.5 K (+49.55 %)
Jan 15 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Option ExerciseM1.2013,50016,2000
Jan 15 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Payment of ExerciseF10.871,49116,20754,48756 K to 54.5 K (-2.66 %)
Jan 15 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...BuyM1.2013,50016,20055,97842.5 K to 56 K (+31.78 %)
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...Option ExerciseA10.8035,000378,00035,000
Feb 04 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SSenior VP - Drug Di ...GrantA0.0054,0000206,630152.6 K to 206.6 K (+35.38 %)
Jan 15 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM3.7835,225133,151164,775
Jan 15 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF10.5512,621133,15272,21884.8 K to 72.2 K (-14.88 %)
Jan 15 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM3.7835,225133,15184,83949.6 K to 84.8 K (+71.00 %)
Jan 03 2014BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF7.608,59265,299504,360513 K to 504.4 K (-1.68 %)
Jan 03 2014BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOPayment of ExerciseF7.602,73520,78682,53985.3 K to 82.5 K (-3.21 %)
Jan 03 2014BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF7.602,45318,64349,61452.1 K to 49.6 K (-4.71 %)
Jan 03 2014BCRXBIOCRYST PHARMACEU ...Barnes Alane PVP, General Counsel ...Payment of ExerciseF7.602,45318,64342,47844.9 K to 42.5 K (-5.46 %)
Jan 03 2014BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryPayment of ExerciseF7.602,40218,255152,630155 K to 152.6 K (-1.55 %)
Nov 13 2013BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorBuyP6.193,00018,5706,0003 K to 6 K (+100.00 %)
Aug 02 2013BCRXBIOCRYST PHARMACEU ...BAKER FELIX10% OwnerBuyP4.4024,705108,702145,533120.8 K to 145.5 K (+20.45 %)
Aug 02 2013BCRXBIOCRYST PHARMACEU ...BAKER FELIX10% OwnerBuyP4.40991,1614,361,1084,832,2853.8 M to 4.8 M (+25.80 %)
Aug 02 2013BCRXBIOCRYST PHARMACEU ...BAKER FELIX10% OwnerBuyP4.40120,498530,1911,642,5131.5 M to 1.6 M (+7.92 %)
Jul 24 2013BCRXBIOCRYST PHARMACEU ...Cohen Fred EDirectorOption ExerciseA3.7220,83377,49920,833
Jun 03 2013BCRXBIOCRYST PHARMACEU ...SANDERS CHARLES ADirectorOption ExerciseA1.7115,00025,65015,000
Jun 03 2013BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseA1.7115,00025,65015,000
Jun 03 2013BCRXBIOCRYST PHARMACEU ...Jensen PederDirectorOption ExerciseA1.7115,00025,65015,000
Jun 03 2013BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorOption ExerciseA1.7115,00025,65015,000
Jun 03 2013BCRXBIOCRYST PHARMACEU ...Erck Stanley CDirectorOption ExerciseA1.7115,00025,65015,000
Jun 03 2013BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorOption ExerciseA1.7115,00025,65015,000
May 29 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOOption ExerciseM1.2016,40719,6880
May 29 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOBuyM1.2016,40719,68882,27465.9 K to 82.3 K (+24.91 %)
May 28 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseM1.20179,600215,520100,000
May 28 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOBuyM1.20179,600215,520509,952330.4 K to 510 K (+54.37 %)
Mar 14 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOGrantA1.383,0004,140340,225337.2 K to 340.2 K (+0.89 %)
Mar 14 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...GrantA1.382,7453,78852,60949.9 K to 52.6 K (+5.50 %)
Mar 14 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOGrantA1.383,0004,14067,65664.7 K to 67.7 K (+4.64 %)
Mar 06 2013BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorBuyP1.233,0003,6903,0000 to 3 K
Mar 06 2013BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryPayment of ExerciseF1.191,9032,265155,032156.9 K to 155 K (-1.21 %)
Mar 06 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOPayment of ExerciseF1.191,7892,12962,86764.7 K to 62.9 K (-2.77 %)
Mar 06 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF1.1954264549,32249.9 K to 49.3 K (-1.09 %)
Mar 06 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF1.195,9677,101331,258337.2 K to 331.3 K (-1.77 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseA1.42184,000261,280184,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseA1.42184,000261,280184,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOGrantA0.0033,2530337,225304 K to 337.2 K (+10.94 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOGrantA0.0033,2530303,972270.7 K to 304 K (+12.28 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...GrantA0.008,500049,86441.4 K to 49.9 K (+20.55 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...GrantA0.008,500041,36432.9 K to 41.4 K (+25.86 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOOption ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOOption ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOGrantA0.008,500064,65656.2 K to 64.7 K (+15.14 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Sheridan William PSR VP - CMOGrantA0.008,500056,15647.7 K to 56.2 K (+17.84 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryOption ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryOption ExerciseA1.4250,00071,00050,000
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryGrantA0.008,5000156,935148.4 K to 156.9 K (+5.73 %)
Jan 07 2013BCRXBIOCRYST PHARMACEU ...Babu Yarlagadda SVP Drug DiscoveryGrantA0.008,5000148,435139.9 K to 148.4 K (+6.07 %)
Dec 17 2012BCRXBIOCRYST PHARMACEU ...Jensen PederDirectorBuyP1.5120,00030,20060,00040 K to 60 K (+50.00 %)
Jul 02 2012BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Payment of ExerciseF3.978,11332,20931,61739.7 K to 31.6 K (-20.42 %)
Jun 05 2012BCRXBIOCRYST PHARMACEU ...Jensen PederDirectorBuyP3.1820,00063,68040,00020 K to 40 K (+100.00 %)
May 25 2012BCRXBIOCRYST PHARMACEU ...Erck Stanley CDirectorOption ExerciseA3.3215,00049,80015,000
May 25 2012BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorOption ExerciseA3.3215,00049,80015,000
May 25 2012BCRXBIOCRYST PHARMACEU ...HIGGINS JOHN LDirectorOption ExerciseA3.3215,00049,80015,000
May 24 2012BCRXBIOCRYST PHARMACEU ...HOROVITZ ZOLA PDirectorOption ExerciseA3.3215,00049,80015,000
May 24 2012BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorOption ExerciseA3.3215,00049,80015,000
May 24 2012BCRXBIOCRYST PHARMACEU ...Jensen PederDirectorOption ExerciseA3.3215,00049,80015,000
May 24 2012BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseA3.3215,00049,80015,000
May 24 2012BCRXBIOCRYST PHARMACEU ...SANDERS CHARLES ADirectorOption ExerciseA3.3215,00049,80015,000
Mar 19 2012BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOPayment of ExerciseF5.2313,61271,191267,719281.3 K to 267.7 K (-4.84 %)
Mar 19 2012BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOGrantA0.0041,9470281,331239.4 K to 281.3 K (+17.52 %)

Page:   < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >

Contact us | Follow us on Twitter